03:39 AM EST, 11/10/2025 (MT Newswires) -- Eric Venker, President & Immunovant Chief Executive Officer, on November 07, 2025, sold 200,000 shares in Roivant Sciences ( ROIV ) for $4,044,000. Following the Form 4 filing with the SEC, Venker has control over a total of 1,504,959 common shares of the company, with 1,504,959 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1635088/000114036125041214/xslF345X05/form4.xml